Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management of a donor insemination program.

W P Hummel1, L M Talbert

  • 1Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill.

Fertility and Sterility
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization.

Reproductive biomedicine online·2002
Same author

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.

Fertility and sterility·2001
Same author

Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates.

American journal of obstetrics and gynecology·2000
Same author

Modern medical management of endometriosis.

Obstetrics and gynecology clinics of North America·1997
Same author

Assisted reproductive technology: the state of the ART.

Annals of medicine·1997
Same author

Ovulation induction in the estrogenized anovulatory patient.

Seminars in reproductive endocrinology·1996

Donor insemination poses risks from transmitted diseases. Rigorous screening of semen donors, including medical history and lab tests, is crucial to minimize maternal-fetal morbidity and ensure safe practices.

Area of Science:

  • Reproductive Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Microbiologic diseases transmitted via donor insemination pose significant maternal-fetal risks.
  • Fresh semen use is discouraged by the CDC and AFS due to potential hazards.
  • Cryopreservation and quarantine are standard but require robust donor evaluation.

Purpose of the Study:

  • To highlight the risks associated with microbiologic transmission in donor insemination.
  • To emphasize the need for comprehensive screening protocols for semen donors.
  • To advocate for uniform guidelines in managing donor insemination programs.

Main Methods:

  • Review of existing evidence on maternal-fetal morbidity from transmitted diseases.
  • Analysis of current recommendations from health organizations (CDC, AFS).

Related Experiment Videos

  • Proposal for enhanced donor evaluation including history, physical examination, and laboratory testing.

    • Main Results:

    • Fresh semen poses a considerable risk of disease transmission.
    • Thorough donor screening is essential to mitigate these risks.
    • Standardized protocols are necessary for effective donor management.

    Conclusions:

    • Donor insemination programs must implement stringent donor evaluation processes.
    • Genetic and microbiologic screening are vital before semen donor selection and use.
    • Minimizing risks requires uniform, rigorous procedures in artificial insemination by donor programs.